Pilot Evaluation Of The StarGuide Next Generation SPECT/CT System

Overview

About this study

The goal of this pilot study is to evaluate capabilities of the StarGuide NextGen SPECT/CT system to inform future clinical use of this technology.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

* Scheduled for clinical administration of a radiopharmaceutical for a clinical nuclear medicine imaging test or radiopharmaceutical therapy
* Able to provide consent for study participation StarGuide NextGen Evaluation

Exclusion Criteria:

* Unable to comply with physical requirements for lying supine on the StarGuide NextGen patient bed
* Pregnant. (Note that pregnancy status will be established via clinical standard of care for the clinical nuclear medicine test prior to administration of radiopharmaceutical.)
* Unable to provide consent for study participation

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 

Eligibility last updated 03/17/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Carrie Hruska

Open for enrollment

Contact information:

Brevin Ndovu

(507) 538-7898

ndovu.brevin@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597992

Mayo Clinic Footer